EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) will report second-quarter 2026 financial results before markets open on July 23, giving investors an update on demand for drug delivery components used by pharmaceutical manufacturers worldwide.
The company will release results before the market opens on Thursday, July 23, followed by a conference call at 8 a.m. Eastern Time to discuss the quarter and its business outlook.
The live webcast will be available at https://edge.media-server.com/mmc/p/g76vb8x6.
Investors who want to ask questions during the conference call must register in advance at https://register-conf.media-server.com/register/BIb8f81e659a244901acaf1d8cef055e07. Registered participants will receive dial-in information and a unique PIN.
Presentation slides will be posted on the day of the call in the investor relations section of the company’s website. A replay of the webcast will remain available for approximately 90 days.
West, headquartered in Exton, employs more than 10,000 people across 50 global sites, including 26 manufacturing facilities. The company reported fiscal 2025 net sales of $3.07 billion and produces more than 41 billion components and devices annually.
Additional company information is available at www.westpharma.com.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.